Mammalian target of rapamycin (mTOR) is a key regulator for cell growth through modulating components of the translation machinery. Previously, numerous pharmacological studies using rapamycin suggested that mTOR has an important role in regulating cardiac hypertrophic growth. To further investigate this assumption, we have generated two lines of cardiac-specific mTOR transgenic mice, kinase dead mTOR and constitutively active mTOR, using  myosin heavy chain promoter. MHC-mTORkd mice had a near complete inhibition of p70S6k and 4E-BP1 phosphorylation, while MHC-mTORca had a significant increase in p70S6k and 4E-BP1 phosphorylation. Although the cardiac function of MHC-mTORkd mice was significantly altered, the cardiac morphology of these transgenic mice was normal. The cardiac hypertrophic growth in response to physiological and pathological stimuli was not different in MHC-mTORkd and MHC-mTORca transgenic mice when compared to that of non-transgenic littermates. These findings suggest that the mTOR mediated signaling pathway is not essential to cardiac hypertrophic growth, but is involved in regulating cardiac function. Additional analysis of cardiac responses to fasting-refeeding or acute insulin administration indicated that MHC-mTORkd mice had a largely impaired physiological response to nutrient-energy supply and insulin stimulation.